Home › Funds › KENFARB & CO. › ABBV

KENFARB & CO. position in ABBV

ABBVIE INC · Health Care

KENFARB & CO. reported holding 12,679 shares of ABBV (ABBVIE INC) in its Q3 2026 13F filing — a position valued at US$3.3M, representing 2.68% of its reported portfolio and ranking #8 among its reported holdings. KENFARB & CO. has disclosed ABBV holdings in 2 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)12.68K sh
Reported value held$3.32M
Portfolio Weight2.68%
First reportedQ3 2023
Last changeAdd
Updated2026-11-14

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

How KENFARB & CO.'s ABBV position evolved

KENFARB & CO. first disclosed a stake in ABBV in Q3 2023 at 10,750 shares (US$1.6M). The position peaked in Q3 2026 at 12,679 shares, worth US$3.3M. Across 2 filings, KENFARB & CO. increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 12,679 shares valued at US$3.3M — an increase of 1,929 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 10.75K $1.60M New
Q3 2026 12.68K $3.32M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABBV and 13F data

ABBV (ABBVIE INC) is a Health Care company. 31 other funds we track also report a position in ABBV — the largest reported positions include Vanguard Group (US$41.31B), BlackRock Inc (US$38.97B), VANGUARD CAPITAL MANAGEMENT LLC (US$30.26B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABBV

All ABBV fund holders →

FAQ

How long has KENFARB & CO. held ABBV?

KENFARB & CO. has disclosed ABBV holdings in 2 of the last 13 reported quarters, going back to Q3 2023.

What is KENFARB & CO.'s current position in ABBV?

As of Q3 2026, KENFARB & CO. holds 12.68K shares of ABBV (ABBVIE INC), valued at $3.32M, representing 2.68% of its reported portfolio and ranking #8.

Has KENFARB & CO. been buying or selling ABBV?

In the latest 13F filing (Q3 2026), KENFARB & CO. increased its position in ABBV. The position peaked in Q3 2026 at 12.68K shares.

Which other funds hold ABBV?

Other major institutional holders of ABBV include Vanguard Group, BlackRock Inc, VANGUARD CAPITAL MANAGEMENT LLC, among 31 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.